BC
TELA icon

Birchview Capital’s TELA Bio TELA Stock Holding History

Birchview Capital’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-155,000
Closed -$231K – 78
2025
Q3 		$231K Hold
155,000
– – 0.17% 61
2025
Q2 		$301K Hold
155,000
– – 0.3% 52
2025
Q1 		$189K Buy
155,000
+30,000
+24% +$73.8K 0.16% 54
2024
Q4 		$378K Buy
+125,000
New +$351K 0.31% 41

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Birchview Capital's TELA Position: Q4 2025 in Review

Birchview Capital sold out of TELA Bio (TELA) in Q4 2025, closing a stake of 155,000 shares — an estimated $231K sold.

Birchview Capital first reported a position in TELA in Q4 2024 and held it in 4 quarters. The position peaked at $378K in Q4 2024. 42 funds tracked by Wall St. Rank hold TELA as of Q4 2025.

  • Birchview Capital reported no remaining TELA Bio position as of Q4 2025 after selling out during the quarter.
  • Birchview Capital sold 155,000 TELA Bio shares in Q4 2025, an estimated $231K.
  • Birchview Capital first reported a position in TELA Bio in Q4 2024 and held it in 4 quarters.
  • Birchview Capital's TELA Bio position peaked at $378K in Q4 2024.
  • 42 funds tracked by Wall St. Rank held TELA Bio as of Q4 2025.

Based on Birchview Capital's 13F filing for Q4 2025, filed 13 Feb 2026.